Navigation Links
Genetic Engineering & Biotechnology News reports on growing use of cell-based assays
Date:4/16/2008

New Rochelle, NY, April 16, 2008Biotech and pharma companies are increasingly relying on cell-based assays in early drug discovery work, reports Genetic Engineering & Biotechnology News (GEN). The technique can provide a quick and lower cost means of testing drug candidates for toxic effects, according to an article in the April 15 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2437).

Better screening technologies, noninvasive monitoring, and more automation are driving the trend toward adoption of this technology, notes John Sterling, Editor-in-Chief of GEN. Some estimates project that the market for cell-based assays will more than double over the next six or seven years to over $230 million. This is definitely a methodology that should draw the interest of new drug developers.

More than 50% of currently marketed drugs target GPCRs, which impact a wide range of cellular processes. Multispan is looking to exploit this area and is collaborating with Promega and Molecular Devices to develop an array of applications for its GPCR cell-based assays.

Another field of much R&D interest involves protein-protein interactions. DiscoveRx created a new family of cell-based assays for the detection of protein-protein interactions using an enzyme fragment complementation assay. This system uses an enzyme acceptor, an inactive alpha-galactosidase enzyme that binds to its enzyme donor forming an active enzyme that will hydrolyze a substrate and provide a signal.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2018)... ... August 28, 2018 , ... ... the full power of positron emission tomography (PET), today launched its proprietary ... is helping clinicians and researchers study and cure debilitating diseases, earlier, and ...
(Date:8/23/2018)... ... ... mini Australian shepherd and a tripod. When Mandy was four years old, she broke her ... repair the leg and each time it was unsuccessful. Once she finally got her ... decided to amputate. With only one front leg, mobility in Mandy’s back legs became ...
(Date:8/21/2018)... ... August 20, 2018 , ... ... today announced that Seattle-based Aptevo Therapeutics , a clinical-stage biotechnology company, ... the Genedata Biologics ® platform to facilitate expansion of their pipeline ...
Breaking Biology News(10 mins):
(Date:9/15/2018)... ... 2018 , ... Nationally recognized public accounting and consulting firm Cherry Bekaert ... the Firm’s Nashville practice, on her appointment to Launch Tennessee’s Board of ... Managing Partner of the Firm’s Nashville practice in December 2017 . In this role, ...
(Date:9/12/2018)... , ... September 10, 2018 , ... Franz Inc. ... Database technology, AllegroGraph , for Knowledge Graphs, and Semantic Web Company , ... solutions, today announced a partnership to develop the Noam Chomsky Knowledge Graph. ...
(Date:9/12/2018)... ... September 11, 2018 , ... Sterlitech ... sheet Forward Osmosis (FO) membranes from Fluid Technology Solutions (FTS H2O) to their ... H2O are constructed from cellulose triacetate (CTA) material. The highly hydrophilic nature of ...
(Date:9/7/2018)... ... , ... Now available on live stream, the NanoScientific Symposium on SPM at ... a panel of industry leaders from Harvard, Cornell, RPI, IBM, SUNY and more to ... in the field. Register today to be a part of the nanometrology conference ...
Breaking Biology Technology: